NHS Availability and Private Prescription Options As of early 2025, Mounjaro is not routinely available on the NHS for weight management, although it is licensed for this indication by the Medicines and Healthcare products Regulatory Agency (MHRA)
While there is no physiological withdrawal syndrome, stopping Wegovy suddenly often results in rapid return of hunger and weight regain
2 BallL.AccottoG.-P.BechtoldU.CreissenG.FunckD.JimenezA.et al (2004)
Further increases (to 1 mg or 2 mg weekly) are considered if additional blood sugar control or weight loss is needed
For non-urgent palpitations that are brief, infrequent, and not associated with concerning symptoms, patients should still discuss them with their prescribing clinician at the next scheduled review
Reduced blood pressure and improved lipids and endothelial/myocardial function have been seen in pre-clinical and clinical studies and have the potential to improve cardiovascular outcomes